MYCN and retinoblastoma: However, one of the challenges with identifying retinoblastomas driven exclusively by MYCN amplification is excluding all possible mechanisms of RB1 gene inactivation including SNVs, indels, LOH, deletions, translocations and promoter hypermethylation.